Best Reads Of The Week With Brianna Labuskes
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
FDA
421-440 of 478 results
-
-
Today鈥檚 Special: Obamacare Menu Labeling Rules Ushered In
Restaurants, convenience stores, vending machines and pizza delivery services are among the businesses that will have to provide calories counts to consumers.
-
Dissecting The Rhetoric Vs. Reality Of Trump鈥檚 Tough Talk On Drug Prices
President Donald Trump鈥檚 upcoming speech on drug prices comes after months of public comments and debate about tackling the issue.
-
Study: Nearly Three-Quarters Of Commonly Used Medical Scopes Tainted By Bacteria
The 鈥榮cary鈥 findings show a discouraging lack of progress in cleaning the devices, despite more vigorous efforts in the wake of deadly superbug outbreaks, experts say.
By Chad Terhune -
Safety Violations Compound Pain Of Painkiller Shortages
California and federal officials have cracked down on a major compounding pharmacy they say posed a threat to public safety, but their actions are worsening shortages of medications that doctors rely on to keep their patients out of pain.
-
Medical Marijuana鈥檚 鈥楥atch-22鈥: Federal Limits On Research Hinder Patients’ Relief
Suffering Americans seek medical marijuana as an alternative to opioids and other powerful pharmaceuticals. Though legal in 29 states, some doctors say the lack of strong data makes it hard to recommend.
By Marisa Taylor and Melissa Bailey -
C-SPAN: FDA Commissioner Scott Gottlieb Talks To KHN
Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN鈥檚 "Newsmakers" program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Health Law Fix Misses The Spending Bill Train
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
-
FDA Moves To Cut Nicotine In Cigarettes, Helping Smokers Kick Habit
In a historic move, the Food and Drug Administration stated its intent Thursday to require tobacco companies to cut nicotine levels in their products to make them less addictive. Stripping cigarettes of addictive power could lead an estimated 5 million adults to quit smoking within a year of the plan.
By Liz Szabo -
In An Effort To Curb Drug Costs, States Advance Bills To Prod Feds On Importation
Legislatures in blue and red states alike are considering proposals that would allow them to import prescription drugs from Canada.
-
FDA Head Vows To Tackle High Drug Prices And Drugmakers 鈥楪aming The System鈥
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he鈥檚 doing to spur competition and bring down drug prices.
By Sarah Jane Tribble and Liz Szabo -
How The Shutdown Might Affect Your Health
For some federal health programs, a shuttered government means business as usual. But the congressional impasse over funding will hit others hard.
-
Grassley Calls For 鈥楥orrective Action鈥 On Abuses In Herpes Vaccine Research
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.
-
FDA Chief Says He鈥檚 Open To Rethinking Incentives On Orphan Drugs
The FDA鈥檚 Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
-
Unregulated Herpes Experiments Expose 鈥楤lack Hole鈥 Of Accountability
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
-
Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.
Some of the nation鈥檚 most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
-
Cities, Counties and Schools Sidestep FDA Canadian Drug Crackdown, Saving Millions
Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.
-
FDA Raids Florida Stores That Consumers Use To Buy Drugs From Canada
The federal agents warned store owners that importing drugs from foreign countries is illegal and that those helping 鈥渁dminister鈥 such medicines could face penalties.
-
To Wage War On Superbugs, FDA Clears Way For Scope With A Disposable Piece
Agency says a removable cap will lower the risk of antibiotic resistant infections but some experts see it as a modest step in curbing the sort of deadly outbreaks that occurred a few years ago.
By Chad Terhune -
The Orphan Drug Machine
FDA Moves To Guard Against Abuse Of 鈥極rphan Drug鈥 Program
Following a KHN investigation, the Food and Drug Administration has moved to speed up approvals of 鈥渙rphan drugs鈥 while closing a loophole that allowed drugmakers to skip pediatric testing.